Detalhe da pesquisa
1.
Performance of magnetic resonance imaging-based prostate cancer risk calculators and decision strategies in two large European medical centres.
BJU Int
; 133(3): 278-288, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607322
2.
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer.
BJU Int
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725182
3.
Evolution of European prostate cancer screening protocols and summary of ongoing trials.
BJU Int
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469728
4.
Shifting risk-stratified early prostate cancer detection to a primary healthcare setting.
BJU Int
; 131(5): 596-601, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408660
5.
External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort.
World J Urol
; 41(1): 13-18, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245015
6.
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
Prostate
; 82(7): 876-879, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254666
7.
Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.
Histopathology
; 80(7): 1041-1049, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384019
8.
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
Histopathology
; 80(3): 558-565, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706119
9.
NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome.
BJU Int
; 130(5): 628-636, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536200
10.
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit.
Stat Med
; 41(12): 2115-2131, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35146793
11.
Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.
BMC Urol
; 22(1): 110, 2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850672
12.
Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growth.
Ann Diagn Pathol
; 56: 151842, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717190
13.
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
N Engl J Med
; 378(19): 1767-1777, 2018 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29552975
14.
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
Mod Pathol
; 34(1): 184-193, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686748
15.
Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative.
J Urol
; 206(1): 62-68, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617330
16.
Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
J Urol
; 205(4): 1100-1109, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207138
17.
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.
BJU Int
; 127(1): 96-107, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32531869
18.
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?
BJU Int
; 128 Suppl 3: 36-44, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374190
19.
Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.
World J Urol
; 39(1): 73-80, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279141
20.
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
World J Urol
; 39(7): 2491-2497, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079252